Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endometrial Carcinoma
|
326 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.050 | 0.800 | 5 | 2004 | 2015 | ||||
Addictive Behavior
|
56 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.040 | 1.000 | 4 | 2004 | 2013 | ||||
Malignant neoplasm of endometrium
|
197 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.040 | 0.750 | 4 | 2004 | 2013 | ||||
Dysphoric mood
|
6 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.020 | 1.000 | 2 | 2004 | 2006 | ||||
Anorexia
|
10 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1 | 2004 | 2004 | |||||
Methamphetamine abuse
|
4 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||
Phobic anxiety disorder
|
7 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||
Major Depressive Disorder
|
1451 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 1.000 | 23 | 2005 | 2019 | ||||
Attention deficit hyperactivity disorder
|
420 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 0.950 | 20 | 2005 | 2017 | ||||
Unipolar Depression
|
225 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 1.000 | 11 | 2005 | 2019 | ||||
Malignant neoplasm of prostate
|
1082 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.090 | 0.667 | 9 | 2005 | 2016 | ||||
Prostate carcinoma
|
1168 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.090 | 0.667 | 9 | 2005 | 2016 | ||||
Drug-induced tardive dyskinesia
|
67 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.050 | 0.600 | 5 | 2005 | 2016 | ||||
Tardive Dyskinesia
|
67 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.050 | 0.600 | 5 | 2005 | 2016 | ||||
Neuralgia
|
16 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.030 | 0.667 | 3 | 2005 | 2019 | ||||
NEUROTICISM
|
54 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.030 | 1.000 | 3 | 2005 | 2017 | ||||
Cancer Pain
|
4 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Female Breast Carcinoma
|
15 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.020 | 1.000 | 2 | 2005 | 2013 | ||||
Malignant neoplasm of female breast
|
15 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.020 | 1.000 | 2 | 2005 | 2013 | ||||
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
|
5 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Marijuana Abuse
|
23 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 0.909 | 11 | 2006 | 2017 | ||||
Mental disorders
|
149 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.100 | 1.000 | 11 | 2006 | 2018 | ||||
Impulsive Behavior
|
69 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.080 | 1.000 | 8 | 2006 | 2014 | ||||
Migraine Disorders
|
264 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.060 | 0.667 | 6 | 2006 | 2019 | ||||
Impaired cognition
|
348 | 0.442 | 0.920 | 22 | 19963748 | missense variant | G/A | snv | 0.46 | 0.44 | 0.050 | 1.000 | 5 | 2006 | 2019 |